NASDAQ:ADMS
Delisted
Adamas Pharmaceuticals Stock News
$8.22
+0 (+0%)
At Close: May 27, 2022
Adamas to Present at Upcoming Piper Sandler Conference
04:02pm, Wednesday, 18'th Nov 2020
EMERYVILLE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to peopl
Adamas Announces New Employment Inducement Grant
04:05pm, Friday, 13'th Nov 2020
EMERYVILLE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company's board of directors granted three new
Adamas Pharmaceuticals: Unjustified Sell-Off Following Another Strong Quarter
02:43am, Friday, 13'th Nov 2020
Adamas Pharmaceuticals recently reported its Q3 earnings with a slight beat on EPS and a slight miss on revenue. The company did report record product sales for GOCOVRI. Adamas looks to have found a r
Adamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q3 2020 Results -Earnings Call Transcript
07:02am, Sunday, 08'th Nov 2020
Adamas Pharmaceuticals' (ADMS) CEO Neil McFarlane on Q3 2020 Results -Earnings Call Transcript
Adamas Reports Third Quarter 2020 Financial Results
04:03pm, Thursday, 05'th Nov 2020
Third quarter 2020 total revenues of $20.2 million, a 45% increase over third quarter 2019
Adamas announces settlement agreement of previously disclosed class action litigation
09:25am, Monday, 02'nd Nov 2020
EMERYVILLE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to peopl
Chrono Trigger at 25: Into the Future
09:40pm, Friday, 21'st Aug 2020
All this week, I’ve been writing a series of articles about my favorite game of all time, Chrono Trigger, as it reaches its 25th anniversary. I’ve held up the game’s story, characters, …
Adamas Announces New Employment Inducement Grant
08:04pm, Friday, 14'th Aug 2020
EMERYVILLE, Calif., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the company’s board of directors granted three ne
Is Adamas Stock Still Worth Buying After Its 77% Rally? This 5-Star Analyst Says ‘Yes’
12:06am, Wednesday, 12'th Aug 2020
It has been hard going for long term investors of Adamas Pharmaceuticals (ADMS). The stock has been down trending since the start of 2018. However, at long last investors had something to cheer about.
The Daily Biotech Pulse: Novavax Vaccine Deals, Trevena Awaits FDA Decision, 2 IPOs
12:00am, Friday, 07'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 6)
ADiTx Therapeutics Inc (NASDAQ: ADTX) (announced introduction of AditxtScore for COVID-19 to be used in detecting...
Adamas Reports Second Quarter 2020 Financial Results
08:02pm, Thursday, 06'th Aug 2020
Second quarter 2020 GOCOVRI® product sales of $18.0 million, a 41% increase over second quarter 2019 Total paid prescriptions grew to 8,150, a 32% increase over second quarter 2019EMERYVILLE, Calif.
The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO
12:00am, Thursday, 06'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
ABIOMED, Inc. (NASDAQ: ABMD)
Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) (announced a U.S. government grant for a...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Will Adamas Pharmaceuticals (ADMS) Report Negative Earnings Next Week? What You Should Know
04:33pm, Thursday, 30'th Jul 2020
Adamas (ADMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adamas to Announce Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020
08:02pm, Thursday, 23'rd Jul 2020
EMERYVILLE, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report 2020 second quarter financial results on Thursday, August
